PET and SPECT for radiation treatment planning

Area of Science:

• Neuroimaging
• Radiation Oncology
• Oncology

Background:

• Positron emission tomography (PET) and single photon computed emission tomography (SPECT) are imaging modalities used in radiation treatment planning for primary brain tumors.
• Fluorodeoxyglucose-PET has limited utility due to high physiologic glucose uptake in normal brain tissue, complicating tumor delineation.
• Magnetic resonance imaging (MRI) can show abnormalities but may not fully capture tumor extent.

Purpose of the Study:

• To evaluate the utility of PET and SPECT with radiolabeled amino acids for radiation treatment planning in patients with primary brain tumors.
• To compare the specificity of amino acid uptake with MRI signal abnormalities for identifying viable tumor tissue.
• To assess the ability of amino acid-based imaging to visualize infiltrative glioma growth.

Main Methods:

• Utilized PET and SPECT imaging with radiolabeled amino acids or analogues.
• Assessed amino acid uptake as a marker for viable tumor tissue.
• Correlated imaging findings with tumor characteristics and treatment planning.

Main Results:

• PET/SPECT with radiolabeled amino acids provide valuable information for glioma delineation.
• Increased amino acid uptake is a more specific marker for viable tumor tissue than MRI abnormalities.
• Amino acid uptake is often increased in tumor regions without blood-brain barrier disruption, revealing infiltrative growth.

Conclusions:

• PET and SPECT with radiolabeled amino acids offer a unique approach for visualizing infiltrative glioma growth.
• This imaging information is crucial for accurate radiation treatment planning in glioma patients.
• Amino acid-based imaging enhances the precision of radiation targeting for brain tumors.